☰

Yoon-Jae Cho, M.D., Ph.D. - Publications

Affiliations: 
Pediatric Neurology Oregon Health and Science University, Portland, OR 
Area:
Neuro-oncology
Tree Info Grants Similar researchers PubMed Report error

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Garancher A, Suzuki H, Haricharan S, Masihi MB, Rusert JM, Norris PS, Carrette F, Romero MM, Morrissy SA, Skowron P, Cavalli FMG, Farooq H, Ramaswamy V, Morcavallo A, Henderson JJ, ... ... Cho Y, et al. Abstract IA11: Overcoming immune evasion in pediatric brain tumors Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-Ia11  0.371
2019 Garancher A, Suzuki H, Haricharan S, Masihi MB, Rusert JM, Norris PS, Carrette F, Romero MM, Morrissy SA, Skowron P, M.G. Cavalli F, Farooq H, Ramaswamy V, J.M. Jones S, Moore RA, ... ... Cho Y, et al. IMMU-03. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA Neuro-Oncology. 21: ii93-ii93. DOI: 10.1093/Neuonc/Noz036.124  0.317
2018 Bakhshinyan D, Venugopal C, Adile AA, Garg N, Manoranjan B, Hallett R, Wang X, Mahendram S, Vora P, Vijayakumar T, Subapanditha M, Singh M, Kameda-Smith MM, Qazi M, McFarlane N, ... ... Cho YJ, et al. BMI1 is a therapeutic target in recurrent medulloblastoma. Oncogene. PMID 30348991 DOI: 10.1038/S41388-018-0549-9  0.401
2018 Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, ... ... Cho YJ, et al. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121. PMID 30297829 DOI: 10.1038/S41467-018-06564-9  0.344
2018 Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, ... ... Cho YJ, et al. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 11. PMID 30206138 DOI: 10.1126/Scisignal.Aau5147  0.372
2018 Nitta R, Bolin SM, Nwagbo G, Purzner T, Kahn S, Cho Y, Li G. Abstract LB-322: Casein kinase 2 is a major regulator of medulloblastoma growth Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-322  0.383
2017 Henderson JJ, Wagner JP, Hofmann NE, Eide CA, Cho YJ, Druker BJ, Davare MA. Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell line. Pediatric Blood & Cancer. PMID 28409891 DOI: 10.1002/Pbc.26553  0.429
2017 Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, ... ... Cho YJ, et al. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9. PMID 28298418 DOI: 10.1126/Scitranslmed.Aaf2968  0.326
2017 Henderson J, Cho H, Davare M, Tsherniak A, Cowley G, Weir B, Hahn WC, Cho Y. PDTM-36. FUNCTIONAL GENOMIC ANALYSIS OF MYC-AMPLIFIED MEDULLOBLASTOMA NOMINATES THE TGFB PATHWAY AS A CLINICALLY VIABLE TARGET Neuro-Oncology. 19: vi197-vi197. DOI: 10.1093/Neuonc/Nox168.799  0.309
2016 Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, Roussel MF, Finkelstein D, Goumnerova L, Perreault S, Wadhwa E, Cho YJ, Stewart CF, Gilbertson RJ. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell. PMID 27050100 DOI: 10.1016/J.Ccell.2016.03.002  0.376
2016 Rusert JM, Garancher A, Udaka YT, Brabetz S, Esparza LA, Seker-Cin H, Qi L, Kogiso M, Schubert S, Milde T, Cho Y, Li X, Olson JM, Crawford JR, Levy ML, et al. Abstract B37: Chemi-genomic analysis of patient-derived xenografts to identify personalized therapies for medulloblastoma Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B37  0.394
2016 Singh SK, Garg N, Manornajan B, Bakhshinyan D, Venugopal C, Hallett R, Wang KX, Ramaswamy V, Cho Y, Mitra S, Kaplan D, Davis T, Taylor M. Abstract 2475: Bmi1 is a therapeutic target in recurrent medulloblastoma Cancer Research. 76: 2475-2475. DOI: 10.1158/1538-7445.Am2016-2475  0.392
2016 Bolin S, Borgenvik A, Persson C, Rosén G, Sundström A, Qi J, Bradner JE, Weiss WA, Cho Y, Weishaupt H, Swartling FJ. Abstract 2473: Combined BET-bromodomain and CDK2 inhibition in MYC-driven medulloblastoma Cancer Research. 76: 2473-2473. DOI: 10.1158/1538-7445.Am2016-2473  0.405
2015 Staal JA, Lau LS, Zhang H, Ingram WJ, Hallahan AR, Northcott PA, Pfister SM, Wechsler-Reya RJ, Rusert JM, Taylor MD, Cho YJ, Packer RJ, Brown KJ, Rood BR. Proteomic profiling of high risk medulloblastoma reveals functional biology. Oncotarget. 6: 14584-95. PMID 25970789 DOI: 10.18632/Oncotarget.3927  0.39
2015 Fogal V, Babic I, Chao Y, Pastorino S, Mukthavaram R, Jiang P, Cho YJ, Pingle SC, Crawford JR, Piccioni DE, Kesari S. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction. Oncotarget. 6: 1157-70. PMID 25528767 DOI: 10.18632/Oncotarget.2708  0.333
2015 McKinney N, Yuan L, Zhang H, Liu J, Cho YJ, Rushing E, Schniederjan M, MacDonald TJ. EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. Journal of Neuro-Oncology. 121: 109-18. PMID 25258252 DOI: 10.1007/S11060-014-1618-8  0.376
2015 Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Peckham JL, Cho Y, Jackson M, Guillaume DJ, Selden NR, Bigner DD, Nazemi KJ, Green SC, Corless CL, Gultekin S, et al. Abstract A08: IGF1R as a key target in high risk, metastatic medulloblastoma Brain. 75. DOI: 10.1158/1538-7445.Brain15-A08  0.356
2015 Phoenix T, Patmore D, Boop S, Jacus M, Patel Y, Goumnerova L, Perreault S, Wadhwa E, Cho Y, Stewart C, Gilbertson R. MB-19 * MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY Neuro-Oncology. 17: iii24-iii24. DOI: 10.1093/Neuonc/Nov061.95  0.391
2015 Wang A, Partap S, Yeom K, Martinez M, Vogel H, Donaldson S, Fisher P, Perreault S, Cho Y, Gibbs I. Mb-11Impact Of Molecular Sub-Type And Craniospinal Irradiation (Csi) Dose On Relapse Of Medulloblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.87  0.304
2015 Kahn S, Nitta R, Wang K, Gholamin S, Azad T, Zhang M, Cho Y, Taylor M, Mitra S, Weissman I, Cheshier S. MB-01 * NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE Neuro-Oncology. 17: iii19-iii20. DOI: 10.1093/Neuonc/Nov061.77  0.379
2014 Hackett CS, Quigley DA, Wong RA, Chen J, Cheng C, Song YK, Wei JS, Pawlikowska L, Bao Y, Goldenberg DD, Nguyen K, Gustafson WC, Rallapalli SK, Cho YJ, Cook JM, et al. Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma. Cell Reports. 9: 1034-46. PMID 25437558 DOI: 10.1016/J.Celrep.2014.09.046  0.352
2014 Sengupta S, Weeraratne SD, Cho YJ, Pomeroy SL. Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? Cns Oncology. 3: 245-7. PMID 25286034 DOI: 10.2217/Cns.14.27  0.766
2014 Rack PG, Ni J, Payumo AY, Nguyen V, Crapster JA, Hovestadt V, Kool M, Jones DT, Mich JK, Firestone AJ, Pfister SM, Cho YJ, Chen JK. Arhgap36-dependent activation of Gli transcription factors. Proceedings of the National Academy of Sciences of the United States of America. 111: 11061-6. PMID 25024229 DOI: 10.1073/Pnas.1322362111  0.321
2014 Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, ... ... Cho YJ, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/Nm.3613  0.388
2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Cho YJ, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/J.Ccr.2014.02.004  0.621
2014 Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 117: 175-82. PMID 24522717 DOI: 10.1007/S11060-014-1375-8  0.338
2014 Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, ... ... Cho YJ, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 912-25. PMID 24297863 DOI: 10.1158/1078-0432.Ccr-13-2281  0.35
2014 Mitra SS, Gholamin S, Volkmer J, Feroze A, Liu J, Achrol A, Wang L, Sayles L, Zhang M, Sakamoto K, Monje-Deisseroth M, Cho Y, Sweet-Cordero A, Majeti R, Cheshier S, et al. Abstract PR12: Overcoming immune evasion in pediatric hematologic and solid tumor malignancies: A preclinical study using a humanized anti-CD47 antibody Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Pr12  0.362
2014 Tang Y, Schubert S, Qi J, Nguyen B, Masoud S, Vue N, Balansay B, Yu F, Atwood SX, Whitson RJ, Ponnuswami A, Chen S, Gholamin S, Pamelyn WJ, Monje-Diesseroth M, ... ... Cho Y, et al. Abstract B6: Epigenetic regulation of Hedgehog pathway transcriptional output by BET bromodomain proteins Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B6  0.381
2014 Chatley SN, Cades J, Neumann N, Mazzacurati L, Yochum Z, Nugent K, Cho Y, Ewald A, Rudin C, Tran P, Burns TF. Abstract 4771: Identification of inhibitors of TWIST1 as a treatment for lung cancer Cancer Research. 74: 4771-4771. DOI: 10.1158/1538-7445.Am2014-4771  0.399
2014 Bender S, Tang Y, Lindroth AM, Hovestadt V, Zapatka M, Jones DTW, Kool M, Northcott PA, Sturm D, Lichter P, Plass C, Cho Y. Abstract 3084: Epigenetic deregulation in H3.3-K27M mutant pediatric high-grade gliomas Cancer Research. 74: 3084-3084. DOI: 10.1158/1538-7445.Am2014-3084  0.416
2014 Morrissy S, Garzia L, Remke M, Ramaswamy V, Jorgensen F, Wu X, Shah S, Ma Y, Mungall K, Meter TV, Cho Y, Collins P, MacDonald T, Li X, Moore R, et al. Ge-21Drastic Genomic Divergence Of Recurrent Medulloblastoma Invalidates Targeted Therapies Discovered At Diagnosis. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.20  0.406
2014 Cho Y, Tang Y, Schubert S, Willardson M, Bandopadhayay P, Bergthold G, Nguyen B, Masoud S, Vue N, Balansay B, Gholamin S, Cheshier SH, Atwood SX, Whitson RJ, Lee A, ... ... Cho Y, et al. EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Neuro-Oncology. 16: iii25-iii25. DOI: 10.1093/Neuonc/Nou208.9  0.423
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Cho YJ, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/S00401-013-1198-2  0.641
2013 Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Schüller U, Gururangan S, McLendon R, Bigner D, Fouladi M, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. The Lancet. Oncology. 14: 1200-7. PMID 24140199 DOI: 10.1016/S1470-2045(13)70449-2  0.544
2013 Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, ... ... Cho YJ, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nature Genetics. 45: 927-32. PMID 23817572 DOI: 10.1038/Ng.2682  0.665
2013 Dykhuizen EC, Hargreaves DC, Miller EL, Cui K, Korshunov A, Kool M, Pfister S, Cho YJ, Zhao K, Crabtree GR. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature. 497: 624-7. PMID 23698369 DOI: 10.1038/Nature12146  0.359
2013 Yuan L, Zhang H, Liu J, Rubin JB, Cho YJ, Shu HK, Schniederjan M, MacDonald TJ. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration. Molecular Cancer. 12: 18. PMID 23497290 DOI: 10.1186/1476-4598-12-18  0.325
2013 Dykhuizen E, Hargreaves D, Miller E, Cui K, Korshunov A, Kool M, Pfister S, Cho Y, Zhao K, Crabtree G. Abstract PR08: mSWI/SNF (BAF) complexes facilitate decatentation of DNA by topoisomerase IIα Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-Pr08  0.371
2013 Gholamin S, Mitra SS, Richard CE, Achrol A, Kong D, Shin JJ, Monje-Deisseroth M, Cho Y, Weissman I, Cheshier SH. Abstract 5218: Development of Anti-CD47 therapy for pediatric brain tumors. Cancer Research. 73: 5218-5218. DOI: 10.1158/1538-7445.Am2013-5218  0.332
2013 Kool M, Jones DT, Jaeger N, Northcott PA, Hovestadt V, Schueller U, Remke M, Cho Y, Pomeroy S, Taylor MD, Eils R, Korshunov A, Lichter P, Pfister SM. Abstract 4591: Whole genome sequencing of SHH medulloblastomas predicts molecular groups of responders and non-responders to SMO-inhibition . Cancer Research. 73: 4591-4591. DOI: 10.1158/1538-7445.Am2013-4591  0.607
2013 Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... ... Cho Y, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182  0.47
2012 Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 488: 100-5. PMID 22832583 DOI: 10.1038/Nature11284  0.637
2012 Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, ... ... Cho YJ, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature. 488: 106-10. PMID 22820256 DOI: 10.1038/Nature11329  0.728
2012 McKenna ES, Tamayo P, Cho YJ, Tillman EJ, Mora-Blanco EL, Sansam CG, Koellhoffer EC, Pomeroy SL, Roberts CW. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle (Georgetown, Tex.). 11: 1956-65. PMID 22544318 DOI: 10.4161/Cc.20280  0.636
2012 Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Sengupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SL, Cho YJ. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123: 539-52. PMID 22402744 DOI: 10.1007/S00401-012-0969-5  0.733
2012 Pei Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, Witt H, Korshunov A, Read TA, Sun JL, Schmitt EM, Miller CR, Buckley AF, McLendon RE, Westbrook TF, et al. An animal model of MYC-driven medulloblastoma. Cancer Cell. 21: 155-67. PMID 22340590 DOI: 10.1016/J.Ccr.2011.12.021  0.406
2012 Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, et al. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathologica. 123: 529-38. PMID 22134538 DOI: 10.1007/S00401-011-0924-X  0.557
2012 Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, Eberhart CG, Dubuc A, Guettouche T, Cardentey Y, Bouffet E, Pomeroy SL, Marra M, Malkin D, Rutka JT, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathologica. 123: 615-26. PMID 22057785 DOI: 10.1007/S00401-011-0899-7  0.563
2012 Jäger N, Jones DT, Kool M, Zichner T, Hutter B, Sultan M, Cho Y, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz H, Brors B, Northcott PA, Taylor MD, et al. ICGC PedBrain - dissecting the genomic complexity underlying medulloblastoma using whole-genome sequencing Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-P43  0.513
2012 Jones DT, Jaeger N, Cho Y, Pugh TJ, Rausch T, Stuetz A, Zichner T, Weischenfeldt J, Zapatka M, Benes V, Blake J, Northcott PA, Remke M, Witt H, Witt O, et al. Abstract 4872: ICGC PedBrain Tumor - Next-generation sequencing identifies novel subgroup-specific mutations and copy number aberrations in medulloblastoma Cancer Research. 72: 4872-4872. DOI: 10.1158/1538-7445.Am2012-4872  0.669
2012 Pugh TJ, Cho Y, Archer T, Weeraratne D, Jones DTW, Jaeger N, Auclair D, Cibulskis K, Lawrence MS, Ramos AH, Shefler E, Sivachenko A, Tamayo P, Mesirov JP, Gabriel SB, et al. Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity Cancer Research. 72: 4868-4868. DOI: 10.1158/1538-7445.Am2012-4868  0.751
2012 Burns TF, Dobromilskaya I, Murphy SC, Gajula RP, Aziz K, Cho Y, Tran PT, Rudin CM. Abstract 2954: TWIST1 is a critical mediator of KRAS mutant tumorigenesis in human non-small cell lung cancer Cancer Research. 72: 2954-2954. DOI: 10.1158/1538-7445.Am2012-2954  0.422
2012 Kool M, Jones DTW, Remke M, Jaeger N, Korshunov A, Schlanstein M, Northcott PA, Meeteren NSv, Vuurden Dv, Clifford SC, Pietsch T, Bueren AOV, Rutkowski S, Cho Y, McCabe M, et al. Abstract 2492: Integrated genomics on molecular subgroups in medulloblastoma Cancer Research. 72: 2492-2492. DOI: 10.1158/1538-7445.Am2012-2492  0.598
2012 Witt H, Mack SC, Bender S, Ryzhova M, Martin S, Isserlin R, Jones DTW, Northcott PA, Till M, Remke M, Benner A, Hielscher T, Gupta N, Garcia L, Weiss WA, ... ... Cho Y, et al. Abstract 1432: The heterogeneous genomic landscape of posterior fossa ependymoma Cancer Research. 72: 1432-1432. DOI: 10.1158/1538-7445.Am2012-1432  0.422
2012 Weeraratne SD, Archer T, Pugh TJ, Hargreaves D, Yu F, Kautzman A, Jones DTW, Jaeger N, Tamayo P, Mesirov JP, Pfister SM, Lichter P, Crabtree G, Meyerson M, Pomeroy SL, ... Cho Y, et al. Abstract 1313: Mutually exclusive somatic mutations in WNT pathway medulloblastomas reveal a critical interaction between DDX3X and SMARCA4 Cancer Research. 72: 1313-1313. DOI: 10.1158/1538-7445.Am2012-1313  0.77
2011 Priller M, Pöschl J, Abrão L, von Bueren AO, Cho YJ, Rutkowski S, Kretzschmar HA, Schüller U. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6791-801. PMID 21918172 DOI: 10.1158/1078-0432.Ccr-11-1214  0.348
2011 Pomeroy SL, Cho YJ. Molecular fingerprints of medulloblastoma and their application to clinical practice. Future Oncology (London, England). 7: 327-9. PMID 21417897 DOI: 10.2217/Fon.11.15  0.501
2011 Tamayo P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N, Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP. Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1415-23. PMID 21357789 DOI: 10.1200/Jco.2010.28.1675  0.55
2011 Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nature Communications. 2: 180. PMID 21285958 DOI: 10.1038/Ncomms1180  0.554
2011 Weeraratne SD, Amani V, Neiss A, Teider N, Scott DK, Pomeroy SL, Cho YJ. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncology. 13: 165-75. PMID 21177782 DOI: 10.1093/Neuonc/Noq179  0.757
2011 McKenna ES, Tamayo P, Cho Y, Mora-Blanco EL, Sansam CG, Tillman EJ, Koellhoffer EC, Pomeroy SL, Roberts CWM. Abstract 66: Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors Cancer Research. 71: 66-66. DOI: 10.1158/1538-7445.Am2011-66  0.638
2011 Cho Y, Tamayo P, Tsherniak A, Meyerson M, Mesirov JP, Pomeroy SL. Abstract 4760: Molecular classification and risk-stratification in medulloblastoma using an integrative genomic approach Cancer Research. 71: 4760-4760. DOI: 10.1158/1538-7445.Am2011-4760  0.595
2011 Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Cho Y, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158  0.74
2011 Kool M, Koster J, Remke M, Korshunov A, Hielscher T, Witt H, Northcott P, Schouten-van Meeteren A, Clifford S, Pietsch T, Buehren Av, Rutkowski S, Cho Y, Versteeg R, Haberler C, et al. Molecular subtypes in medulloblastoma: an International meta-analysis for profiles, genetic aberrations, clinicopathological features AND SURVIVAL Klinische PäDiatrie. 223. DOI: 10.1055/S-0031-1292590  0.533
2010 Jagani Z, Mora-Blanco EL, Sansam CG, McKenna ES, Wilson B, Chen D, Klekota J, Tamayo P, Nguyen PT, Tolstorukov M, Park PJ, Cho YJ, Hsiao K, Buonamici S, Pomeroy SL, et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nature Medicine. 16: 1429-33. PMID 21076395 DOI: 10.1038/Nm.2251  0.607
2010 Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CW. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 18: 316-28. PMID 20951942 DOI: 10.1016/J.Ccr.2010.09.006  0.602
2010 Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, Wang Y, Marquez VE, Cho YJ, Pomeroy SL. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro-Oncology. 12: 1244-56. PMID 20847082 DOI: 10.1093/Neuonc/Noq091  0.791
2010 Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/Nature08822  0.577
2010 Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho Y, Koelhoffer EC, Pomeroy SL, Orkin SH, Roberts CWM. Abstract LB-237: Epigenetic antagonism between Polycomb and SWI/SNF complexes duringoncogenic transformation Cancer Research. 71: 4799-4799. DOI: 10.1158/1538-7445.Am2011-Lb-237  0.632
2010 Tran P, Shroff E, Thijagarajan S, Das S, Cho Y, Chen J, Luong R, Vicent S, Nielsen C. Reactivation of Oncogene-induced Senescence In Kras Lung Tumors by Inhibition of Twist1 International Journal of Radiation Oncology*Biology*Physics. 78: S128. DOI: 10.1016/J.Ijrobp.2010.07.322  0.407
2008 McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CW. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Molecular and Cellular Biology. 28: 6223-33. PMID 18710953 DOI: 10.1128/Mcb.00658-08  0.604
Show low-probability matches.